Michelson Prizes: Next Generation Grants in Human Immunology

The Michelson Prizes focus on transformative research in human immunology with trans-disease applications to accelerate vaccine and immunotherapy discovery. Reviewers will be looking for research aimed at tackling current roadblocks in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy discovery.

Projects should propose innovative ideas and approaches that can be applied across disease areas and states. Projects should have the potential to significantly expand our understanding of the human immune system and accelerate the development of vaccines, diagnostics, and immunotherapies.

While the Michelson Prizes are focused on research in the fields of immunology, vaccine and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, microbiome, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, environmental health, nanotechnology, etc., are encouraged to apply.

Applicants born before June 12, 1987 are not eligible to apply.